Track the 바디텍메드 share price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares trade on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 바디텍메드 has recorded 3 insider filings. Market capitalisation: €243.8bn. The latest transaction was disclosed on 7 April 2026 (Purchase). Among the most active insiders: 최규리. Every trade is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
바디텍메드 is a health and pharma company focused on the development of medical devices and diagnostic tests. The company is listed on the XKRX market.